139 related articles for article (PubMed ID: 31697829)
1. Swift Efficacy with Infliximab 4 Years after Initial Standard Induction Therapy Followed by Severe Delayed Infusion Reaction in Crohn's Disease.
Chiba M; Tsuji T; Nakane K; Obara Y; Komatsu M
Inflamm Bowel Dis; 2020 Jan; 26(1):e4. PubMed ID: 31697829
[No Abstract] [Full Text] [Related]
2. Thrombophlebitis of cephalic vein in the left forearm related to infliximab infusion.
Huang ZY; Lin L; Tang Q; Wang YF
J Dig Dis; 2016 Nov; 17(11):773-776. PubMed ID: 27598885
[No Abstract] [Full Text] [Related]
3. Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.
Duron C; Goutte M; Pereira B; Bommelaer G; Buisson A
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):705-11. PubMed ID: 25856689
[TBL] [Abstract][Full Text] [Related]
4. [Anorectal adenocarcinoma after Infliximab treatment for fistulizing Crohn's disease].
Smaali J; Sekkach Y
Pan Afr Med J; 2017; 26():172. PubMed ID: 28674565
[No Abstract] [Full Text] [Related]
5. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
6. Induction and Maintenance Infliximab Therapy for the Treatment of Crohn's Disease with Perianal Fistulas in Children: Retrospective, Multicenter Study.
Iwańczak BM; Ryżko J; Jankowski P; Sładek M; Wasilewska A; Szczepanik M; Sienkiewicz E; Szaflarska-Popławska A; Więcek S; Kwiecień J; Korczowski B; Maślana J
Adv Clin Exp Med; 2016; 25(3):523-30. PubMed ID: 27629741
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
Bouguen G; Trouilloud I; Siproudhis L; Oussalah A; Bigard MA; Bretagne JF; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709
[TBL] [Abstract][Full Text] [Related]
8. Short article: Remicade infusions at home: an alternative setting of infliximab therapy for patients with Crohn's disease.
Kuin S; Stolte SB; van den Brink GR; Ponsioen CY; Fockens P; D'Haens GR; Löwenberg M
Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):222-5. PubMed ID: 26566062
[TBL] [Abstract][Full Text] [Related]
9. Fatal staphylococcal sepsis in Crohn's disease after infliximab.
Herrlinger KR; Borutta A; Meinhardt G; Stange EF; Fellermann K
Inflamm Bowel Dis; 2004 Sep; 10(5):655-6. PubMed ID: 15472530
[TBL] [Abstract][Full Text] [Related]
10. Infliximab for fistulas: a hole in one?
Korzenik JR
Inflamm Bowel Dis; 2000 Feb; 6(1):62-3. PubMed ID: 10701153
[No Abstract] [Full Text] [Related]
11. Infliximab and surgical treatment of complex anal Crohn's disease.
Duff S; Sagar PM; Rao M; Dolling S; Sprakes M; Hamlin PJ
Colorectal Dis; 2012 Aug; 14(8):972-6. PubMed ID: 21899707
[TBL] [Abstract][Full Text] [Related]
12. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging.
Karmiris K; Bielen D; Vanbeckevoort D; Vermeire S; Coremans G; Rutgeerts P; Van Assche G
Clin Gastroenterol Hepatol; 2011 Feb; 9(2):130-6. PubMed ID: 21056696
[TBL] [Abstract][Full Text] [Related]
13. Surgical methods of fistula closure in fistulating perianal Crohn's disease.
Khalil I; Bethune R
Colorectal Dis; 2023 Mar; 25(3):498. PubMed ID: 36427019
[No Abstract] [Full Text] [Related]
14. Medical management of fistulising Crohn's disease.
Grimstad T; Carlsen A; Karlsen LN
Tidsskr Nor Laegeforen; 2019 Jan; 139(1):. PubMed ID: 30644688
[No Abstract] [Full Text] [Related]
15. Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.
de Ridder L; Escher JC; Bouquet J; Schweizer JJ; Rings EH; Tolboom JJ; Houwen RH; Norbruis OF; Derkx BH; Taminiau JA
J Pediatr Gastroenterol Nutr; 2004 Jul; 39(1):46-52. PubMed ID: 15187780
[TBL] [Abstract][Full Text] [Related]
16. [Indications and results of infliximab in Crohn's disease].
Karoui S; Boubaker J; Filali A
Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
[TBL] [Abstract][Full Text] [Related]
17. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
[TBL] [Abstract][Full Text] [Related]
18. Management of fistulas in patients with Crohn's disease: antibiotic to antibody.
Paré P
Can J Gastroenterol; 2001 Nov; 15(11):751-6. PubMed ID: 11727005
[TBL] [Abstract][Full Text] [Related]
19. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.
Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F
Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720
[TBL] [Abstract][Full Text] [Related]
20. [Infliximab therapy for Crohn's disease anoperineal lesions].
Ouraghi A; Nieuviarts S; Mougenel JL; Allez M; Barthet M; Carbonnel F; Cosnes J; Gendre JP; Flourié B; Meurisse JJ; Quandalle P; Ernst O; Lemann M; Cortot A; Modigliani R; Colombel JF
Gastroenterol Clin Biol; 2001 Nov; 25(11):949-56. PubMed ID: 11845044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
